BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+4.28%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$2.33T
AUM Growth
+$96B
(+4.3%)
Cap. Flow
+$25.6B
Cap. Flow
% of AUM
1.1%
Top 10 Holdings %
Top 10 Hldgs %
14.6%
Holding
5,147
New
204
Increased
2,832
Reduced
1,527
Closed
125
Top Buys
| 1 |
Dow Inc
DOW
|
+$2.51B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$2.5B |
| 3 |
Corteva
CTVA
|
+$1.73B |
| 4 |
Alibaba
BABA
|
+$1.16B |
| 5 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$1.09B |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$1.8B |
| 2 |
Apple
AAPL
|
+$1.45B |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$1.09B |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$957M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$894M |
Sector Composition
| 1 | Technology | 17.02% |
| 2 | Financials | 14.49% |
| 3 | Healthcare | 13.65% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
GoPro
GPRO
$362M
| $45.6M | ﹤0.01% |
8,358,615
+389,072
| +5% | +$2.12M |
|
2352
Arlo Technologies
ARLO
$1.88B
| $45.4M | ﹤0.01% |
11,320,127
+510,131
| +5% | +$2.05M |
|
2353
Future Fuel
FF
$173M
| $45.3M | ﹤0.01% |
3,875,309
-1,834
| -0% | -$21.4K |
|
|
DSPG
2354
DELISTED
DSP Group Inc
DSPG
| $45.3M | ﹤0.01% |
3,154,232
+1,148,366
| +57% | +$16.5M |
|
2355
iShares Select U.S. REIT ETF
ICF
$1.91B
| $45.3M | ﹤0.01% |
803,752
+10,294
| +1% | +$580K |
|
2356
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$398M
| $45.1M | ﹤0.01% |
976,263
-214,204
| -18% | -$9.9M |
|
2357
Plains GP Holdings
PAGP
$3.69B
| $45.1M | ﹤0.01% |
1,804,297
-180,751
| -9% | -$4.51M |
|
2358
Seaboard Corp
SEB
$3.75B
| $45M | ﹤0.01% |
10,885
-110
| -1% | -$455K |
|
2359
Bally's
BALY
$492M
| $45M | ﹤0.01% |
1,512,639
+1,474,727
| +3,890% | +$43.9M |
|
2360
Central Garden & Pet
CENT
$2.24B
| $44.9M | ﹤0.01% |
2,083,778
+54,112
| +3% | +$1.17M |
|
2361
PagSeguro Digital
PAGS
$3.14B
| $44.8M | ﹤0.01% |
1,150,242
+245,692
| +27% | +$9.57M |
|
|
MODN
2362
DELISTED
MODEL N, INC.
MODN
| $44.8M | ﹤0.01% |
2,296,082
+402,691
| +21% | +$7.85M |
|
2363
Parsons
PSN
$8.08B
| $44.8M | ﹤0.01% |
+1,214,077
| New | +$44.8M |
|
|
IFFT
2364
DELISTED
International Flavors & Fragrances Inc. 6.00% Tangible Equity Units
IFFT
| $44.7M | ﹤0.01% |
831,379
+425,957
| +105% | +$22.9M |
|
|
ANAT
2365
DELISTED
American National Group, Inc. Common Stock
ANAT
| $44.7M | ﹤0.01% |
384,071
-9,330
| -2% | -$1.09M |
|
|
AKCA
2366
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $44.7M | ﹤0.01% |
1,907,412
+21,377
| +1% | +$501K |
|
2367
First Financial Corporation Common Stock
THFF
$681M
| $44.6M | ﹤0.01% |
1,110,677
+29,973
| +3% | +$1.2M |
|
2368
Twist Bioscience
TWST
$1.63B
| $44.4M | ﹤0.01% |
1,532,141
+1,167,949
| +321% | +$33.9M |
|
2369
Community Health Systems
CYH
$409M
| $44.4M | ﹤0.01% |
16,632,530
-75,589
| -0.5% | -$202K |
|
2370
Manitowoc
MTW
$357M
| $44.1M | ﹤0.01% |
2,479,273
+18,250
| +0.7% | +$325K |
|
2371
Hackett Group
HCKT
$569M
| $44.1M | ﹤0.01% |
2,626,276
+466,793
| +22% | +$7.84M |
|
|
RUBY
2372
DELISTED
Rubius Therapeutics, Inc
RUBY
| $44M | ﹤0.01% |
2,794,691
+130,641
| +5% | +$2.06M |
|
2373
Grupo Aeroportuario del Sureste
ASR
$10.1B
| $43.9M | ﹤0.01% |
270,612
-36,318
| -12% | -$5.89M |
|
2374
iShares Global Tech ETF
IXN
$6.06B
| $43.8M | ﹤0.01% |
1,464,294
-4,959,024
| -77% | -$148M |
|
2375
CytomX Therapeutics
CTMX
$323M
| $43.6M | ﹤0.01% |
3,890,049
+25,658
| +0.7% | +$288K |
|